Lenalidomide Capsule 5 mg

Here is the detailed information for:


๐Ÿ’Š Lenalidomide Capsule 5 mg


๐Ÿ“˜ Description

Lenalidomide is an oral immunomodulatory and anti-neoplastic agent. It is a derivative of thalidomide with enhanced potency and reduced side effects. It is used primarily for the treatment of blood cancers.


๐ŸŒฟ Nature / Drug Class

  • Nature: Immunomodulatory agent
  • Drug Class: Immunomodulator / Anti-neoplastic
  • Related to thalidomide, but more potent and better tolerated

๐ŸŽฏ Purpose / Indications

  • Multiple Myeloma (especially in combination with dexamethasone)
  • Myelodysplastic Syndromes (MDS) with 5q deletion
  • Mantle Cell Lymphoma
  • Follicular Lymphoma (off-label)
  • Non-Hodgkinโ€™s Lymphoma (some subtypes)

โœ… Advantages

  • Oral route (capsule) โ€” convenient for long-term therapy
  • Improved efficacy over older agents like thalidomide
  • Slows disease progression and improves survival in multiple myeloma
  • Fewer neurological side effects compared to thalidomide
  • Can modulate immune system, inhibit angiogenesis, and target cancer cell growth

๐Ÿ“ฆ Common Packaging

  • Blister packs or HDPE bottles
  • Usually packed in capsules of 5 mg, 10 mg, 15 mg, or 25 mg
  • Typically comes in a strip of 7 or 21 capsules, depending on regimen

โš ๏ธ Patient Advice / Precautions

  • Pregnancy Category X: Highly teratogenic. Absolutely contraindicated in pregnancy. Use strict birth control.
  • Frequent blood monitoring is required (CBC with differential)
  • Can cause neutropenia, thrombocytopenia, anemia
  • Risk of venous thromboembolism; may require anticoagulant prophylaxis
  • Monitor for signs of infection, fatigue, rash, or neuropathy
  • Not recommended in patients with severe renal impairment without dose adjustment
  • Prescribing and dispensing are strictly regulated under a Risk Evaluation and Mitigation Strategy (REMS) program in many countries

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button